StockData
Design Therapeutics, Inc. logo

Design Therapeutics, Inc. (DSGN) stock

DSGNNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 7/30
$9.84−0.08 (-0.81%)

Close on Nov 17, 2026Market cap $615.80MP/E –Yield –

Design Therapeutics operating margin

Operating margin is operating income as a percentage of revenue.

Design Therapeutics's operating margin for the twelve months ending Dec 31, 2020 was -3685.8%. For fiscal 2020 it was -3685.8%.

Annual operating margin

PeriodPeriod endValueChange (pts)
FY2020Dec 31, 2020-3685.8%–

Quarterly operating margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q4 FY2020Dec 31, 2020-11700.0%–
Q3 FY2020Sep 30, 2020-11915.0%–
Q2 FY2020Jun 30, 2020-4719.4%–
Q1 FY2020Mar 31, 2020-438.7%–

More Design Therapeutics figures

See a number that looks wrong?